Jonas Grossman - 30 Sep 2021 Form 3 Insider Report for Monterey Bio Acquisition Corp

Role: Director
Signature: /s/ Tricia Branker, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 30 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 30 Sep 2021, 17:52:39 UTC
Previous filing: 08 Sep 2021
Next filing: 03 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MTRY	Common Stock						637,500	30 Sep 2021	See footnote	F1, F2
holding	MTRY	Common Stock						35,000	30 Sep 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes up to 93,750 shares subject to forfeiture depending on the extent to which the underwriter's option to purchase additional units is exercised.
F2	The shares are held directly by Chardan Monterey Investments LLC (the "Chardan Co-Sponsor"). The Reporting Person is the managing member of Chardan Co-Sponsor. Accordingly, the Reporting Person has voting and dispositive power over the shares held by Chardan Co-Sponsor and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Content

Includes up to 93,750 shares subject to forfeiture depending on the extent to which the underwriter's option to purchase additional units is exercised.

The shares are held directly by Chardan Monterey Investments LLC (the "Chardan Co-Sponsor"). The Reporting Person is the managing member of Chardan Co-Sponsor. Accordingly, the Reporting Person has voting and dispositive power over the shares held by Chardan Co-Sponsor and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Remarks:

See Exhibit 24.1 - Power of Attorney